Autoimmunity BioSolutions
PrivateLast Round
Seed
May 6, 2026
Momentum Score
50 /100
Company Overview
Autoimmunity BioSolutions is a biotechnology company developing a next-generation, immuno-corrective antibody therapy for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autoimmunity BioSolutions Comps
Public and private peers based on sector, stage, and business model.
Autoimmunity BioSolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 6, 2026 |
Key People
Founding team and executive leadership
Autoimmunity BioSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NewTech Investment Holdings | Seed |
| Alexandria Venture Investments | Seed |
| Independent Capital Group | Seed |
| Eos | Seed |
| Independence Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
Raised $3.2M in Seed funding.
- Feb 17, 2026
Grew 250% QoQ from 2 to 7 employees.
Autoimmunity BioSolutions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Autoimmunity BioSolutions's valuation, stock price, and market status.
